Insider · CIK 0001823398
Brian C Judkins
officer
Files at CHE (CHEMED CORP). First filing Dec 20, 2024, latest Dec 30, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 1
$75k bought, $7.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CHE: CHEMED CORP
CHEOct 9, 2026 · close 499.82
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | CHEbuy CHEMED CORP | $75k 145 shares | +9% | - | |
| 45Moderate | CHEsell CHEMED CORP | $7.2M 11,158 shares | -88% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 21, 2025 | CHE CHEMED CORP | AGrant or award Stock Option (right to buy with tandem tax withholding)derivative | +15,017 | $443.79 | $6.7M | 38,067 | Oct 22, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +556 | $553.39 | $308k | 2,234 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Capital Stock | +168 | $553.39 | $93k | 2,402 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | FTax withholding Capital Stock | -215 | $553.39 | $119k | 2,187 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Performance Stock Unitsderivative | -275 | $0.00 | $0 | 1,489 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | MOption exercise Performance Stock Unitsderivative | -275 | $0.00 | $0 | 1,214 | Feb 18, 2025 |
| Feb 14, 2025 | CHE CHEMED CORP | AGrant or award Performance Stock Unitsderivative | +750 | $0.00 | $0 | 1,964 | Feb 18, 2025 |
| Dec 30, 2024 | CHE CHEMED CORP | POpen-market purchase Capital Stock | +145 | $519.50 | $75k | 1,678 | Dec 30, 2024 |
| Mar 20, 2024 | CHE CHEMED CORP | MOption exercise Capital Stock | +5,825 | $413.19 | $2.4M | 6,558 | Dec 20, 2024 |
| Mar 20, 2024 | CHE CHEMED CORP | MOption exercise Capital Stock | +6,133 | $471.74 | $2.9M | 12,691 | Dec 20, 2024 |
| Mar 20, 2024 | CHE CHEMED CORP | SOpen-market sale Capital Stock | -11,158 | $645.00 | $7.2M | 1,533 | Dec 20, 2024 |
| Mar 20, 2024 | CHE CHEMED CORP | MOption exercise Stock Option (right to buy with tandem tax withholding)derivative | -5,825 | $413.19 | $2.4M | 29,183 | Dec 20, 2024 |
| Mar 20, 2024 | CHE CHEMED CORP | MOption exercise Stock Option (right to buy with tandem tax withholding)derivative | -6,133 | $471.74 | $2.9M | 23,050 | Dec 20, 2024 |
| Oct 22, 2024 | CHE CHEMED CORP | AGrant or award Stock Option (right to buy with tandem tax withholding)derivative | +10,323 | $597.70 | $6.2M | 33,373 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.